Difference between actual and published PK parameters [Study As­sess­ment]

posted by dshah  – India/United Kingdom, 2022-02-15 16:26 (743 d 05:12 ago) – Posting: # 22784
Views: 1,974

Dear Loky do!

❝ does this biphasic nature affect the practical obtained half life of the drug? and is this nature could affect the drug variability?

The biphasic nature (compartmental analysis) would not affect your outcome for BE as NCA is recommended by regulatory bodies. Although as per AusPAR- there is no significant impact of age and Race, your half-life is different than the reported one. Kindly refer pg 27-34 of AusPAR.


Complete thread:

UA Flag
 Admin contact
22,912 posts in 4,806 threads, 1,639 registered users;
29 visitors (0 registered, 29 guests [including 5 identified bots]).
Forum time: 21:38 CET (Europe/Vienna)

Exploratory analysis: The art of finding a Rembrandt
in a Jackson Pollock.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz